![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 13484 |
FusionGeneSummary for FIP1L1_SCFD2 |
![]() |
Fusion gene information | Fusion gene name: FIP1L1_SCFD2 | Fusion gene ID: 13484 | Hgene | Tgene | Gene symbol | FIP1L1 | SCFD2 | Gene ID | 81608 | 152579 |
Gene name | factor interacting with PAPOLA and CPSF1 | sec1 family domain containing 2 | |
Synonyms | FIP1|Rhe|hFip1 | STXBP1L1 | |
Cytomap | 4q12 | 4q12 | |
Type of gene | protein-coding | protein-coding | |
Description | pre-mRNA 3'-end-processing factor FIP1FIP1 like 1FIP1-like 1 proteinFIP1L1 cleavage and polyadenylation specific factor subunitfactor interacting with PAPrearranged in hypereosinophilia | sec1 family domain-containing protein 2syntaxin binding protein 1-like 1 | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q6UN15 | Q8WU76 | |
Ensembl transtripts involved in fusion gene | ENST00000507166, ENST00000358575, ENST00000337488, ENST00000507922, ENST00000306932, ENST00000510668, | ENST00000401642, ENST00000388940, | |
Fusion gene scores | * DoF score | 7 X 8 X 5=280 | 10 X 8 X 10=800 |
# samples | 10 | 11 | |
** MAII score | log2(10/280*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(11/800*10)=-2.86249647625006 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: FIP1L1 [Title/Abstract] AND SCFD2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | STAD | TCGA-BR-7707-01A | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000507166 | ENST00000401642 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
In-frame | ENST00000507166 | ENST00000388940 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
In-frame | ENST00000358575 | ENST00000401642 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
In-frame | ENST00000358575 | ENST00000388940 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
In-frame | ENST00000337488 | ENST00000401642 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
In-frame | ENST00000337488 | ENST00000388940 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
In-frame | ENST00000507922 | ENST00000401642 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
In-frame | ENST00000507922 | ENST00000388940 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
In-frame | ENST00000306932 | ENST00000401642 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
In-frame | ENST00000306932 | ENST00000388940 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
intron-3CDS | ENST00000510668 | ENST00000401642 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
intron-3CDS | ENST00000510668 | ENST00000388940 | FIP1L1 | chr4 | 54266006 | + | SCFD2 | chr4 | 54179930 | - |
Top |
FusionProtFeatures for FIP1L1_SCFD2 |
![]() |
Hgene | Tgene |
FIP1L1 | SCFD2 |
May be involved in protein transport. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000306932 | + | 8 | 15 | 356_406 | 233 | 521 | Compositional bias | Note=Pro-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000306932 | + | 8 | 15 | 456_562 | 233 | 521 | Compositional bias | Note=Arg-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000306932 | + | 8 | 15 | 478_594 | 233 | 521 | Compositional bias | Note=Glu-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000337488 | + | 10 | 18 | 356_406 | 271 | 595 | Compositional bias | Note=Pro-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000337488 | + | 10 | 18 | 456_562 | 271 | 595 | Compositional bias | Note=Arg-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000337488 | + | 10 | 18 | 478_594 | 271 | 595 | Compositional bias | Note=Glu-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000358575 | + | 9 | 18 | 356_406 | 256 | 589 | Compositional bias | Note=Pro-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000358575 | + | 9 | 18 | 456_562 | 256 | 589 | Compositional bias | Note=Arg-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000358575 | + | 9 | 18 | 478_594 | 256 | 589 | Compositional bias | Note=Glu-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000507166 | + | 10 | 24 | 356_406 | 271 | 850 | Compositional bias | Note=Pro-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000507166 | + | 10 | 24 | 456_562 | 271 | 850 | Compositional bias | Note=Arg-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000507166 | + | 10 | 24 | 478_594 | 271 | 850 | Compositional bias | Note=Glu-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000507922 | + | 9 | 12 | 356_406 | 256 | 379 | Compositional bias | Note=Pro-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000507922 | + | 9 | 12 | 456_562 | 256 | 379 | Compositional bias | Note=Arg-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000507922 | + | 9 | 12 | 478_594 | 256 | 379 | Compositional bias | Note=Glu-rich |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000306932 | + | 8 | 15 | 1_356 | 233 | 521 | Region | Note=Necessary for stimulating PAPOLA activity |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000306932 | + | 8 | 15 | 457_490 | 233 | 521 | Region | Arg/Asp/Glu-rich domain |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000337488 | + | 10 | 18 | 1_356 | 271 | 595 | Region | Note=Necessary for stimulating PAPOLA activity |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000337488 | + | 10 | 18 | 457_490 | 271 | 595 | Region | Arg/Asp/Glu-rich domain |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000358575 | + | 9 | 18 | 1_356 | 256 | 589 | Region | Note=Necessary for stimulating PAPOLA activity |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000358575 | + | 9 | 18 | 457_490 | 256 | 589 | Region | Arg/Asp/Glu-rich domain |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000507166 | + | 10 | 24 | 1_356 | 271 | 850 | Region | Note=Necessary for stimulating PAPOLA activity |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000507166 | + | 10 | 24 | 457_490 | 271 | 850 | Region | Arg/Asp/Glu-rich domain |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000507922 | + | 9 | 12 | 1_356 | 256 | 379 | Region | Note=Necessary for stimulating PAPOLA activity |
Hgene | >FIP1L1 | chr4:54266006 | chr4:54179930 | ENST00000507922 | + | 9 | 12 | 457_490 | 256 | 379 | Region | Arg/Asp/Glu-rich domain |
Tgene | SCFD2 | chr4:54266006 | chr4:54179930 | ENST00000388940 | - | 1 | 8 | 120_124 | 335 | 640 | Compositional bias | Note=Poly-Ala |
Tgene | SCFD2 | chr4:54266006 | chr4:54179930 | ENST00000401642 | - | 1 | 9 | 120_124 | 335 | 685 | Compositional bias | Note=Poly-Ala |
Top |
FusionGeneSequence for FIP1L1_SCFD2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FIP1L1_SCFD2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
FIP1L1 | CPSF4, SRRM2, HNRNPA1, COPS5, APP, CPSF1, CPSF2, CPSF3, WDR33, NUP153, LIG4, CSNK2A1, HDAC9, CLK2, PRMT2, PRMT6, WWOX, STAU1, GOLGA2, SGTA, NAA10, ZMYND19, CUL7, OBSL1, EZH2, SUZ12, RNF2, EAF1, CPSF4L, NTRK1, HIST1H1C, PCF11, CSTF2T, PAPOLA, CSTF3, MED4, SRPK2, XPO1, CSTF1, CSTF2, LSS, P4HA1, P4HB, PML, SYMPK, P4HA2, CRTAP, WWP2, KIF2A, LLGL2, SEC16A, POLK, KIF21A, CDCA5, CEP170P1, FOXL2, ESR1, SNW1, ZC3H18, PDHA1, FOXA1 | SCFD2 | USE1, STX12, NAPG, SIRT2, RINT1, NBAS, SEC22B, BNIP1, ZW10, C19orf25, VAMP4, STX18 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FIP1L1_SCFD2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for FIP1L1_SCFD2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FIP1L1 | C1540912 | Hypereosinophilic syndrome | 1 | CTD_human |